Hoover Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hoover Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$40K	Hold	292	–	–	0.01%	310
2021 Q1	$37K	Hold	292	–	–	0.01%	292
2020 Q4	$45K	Buy	292 +1	+0.3%	+$128	0.01%	248
2020 Q3	$32K	Hold	291	–	–	0.01%	146
2020 Q2	$33K	Buy	+291	New	+$28.7K	0.01%	228

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Hoover Financial Advisors's XBI Position: Q2 2021 in Review

Hoover Financial Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2021 at 292 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #310.

Hoover Financial Advisors first reported a position in XBI in Q2 2020 and has held it in 5 quarters since. The position peaked at $45K in Q4 2020. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

Hoover Financial Advisors held 292 shares of State Street SPDR S&P Biotech ETF worth $40K as of Q2 2021.
Hoover Financial Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2021.
State Street SPDR S&P Biotech ETF made up 0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #310 holding.
Hoover Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 5 quarters since.
Hoover Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $45K in Q4 2020.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.